Rosuvastatin alleviates high-salt and cholesterol diet-induced cognitive impairment in rats via Nrf2–ARE pathway

References

• Rossor M, Collinge J, Fox N, et al. Dementia and cognitive impairment. In: Clarke Charles, Howard Robin, Rossor Martin, et al., editors. Neurology: A Queen Square Textbook. London: Wiley Blackwell; 2016. p. 289–336 10.1002/9781118486160
   Google Scholar
• Robinson L, Tang E, Taylor J-P. Dementia: timely diagnosis and early intervention. BMJ. 2015;350:h3029.
   PubMed Web of Science ®Google Scholar
• Baumgart M, Snyder HM, Carrillo MC, et al. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimer's Dementia. 2015;11(6):718–726.
   PubMed Web of Science ®Google Scholar
• Beilharz JE, Maniam J, Morris MJ. Diet-induced cognitive deficits: the role of fat and sugar, potential mechanisms and nutritional interventions. Nutrients. 2015;7(8):6719–6738.
   PubMed Web of Science ®Google Scholar
• Okereke OI, Rosner BA, Kim DH, et al. Dietary fat types and 4-year cognitive change in community-dwelling older women. Ann Neurol. 2012;72(1):124–134.
   PubMed Web of Science ®Google Scholar
• Liu Y-Z, Chen J-K, Li Z-P, et al. High-salt diet enhances hippocampal oxidative stress and cognitive impairment in mice. Neurobiol Learn Mem. 2014;114:10–15.
   PubMed Web of Science ®Google Scholar
• Mogi M, Tsukuda K, Li J-M, et al. Inhibition of cognitive decline in mice fed a high-salt and cholesterol diet by the angiotensin receptor blocker, olmesartan. Neuropharmacology. 2007;53(8):899–905.
   PubMed Web of Science ®Google Scholar
• Panza F, Frisardi V, Capurso C, et al. Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. J Alzheimer's Dis. 2010;21(3):691–724.
   PubMed Web of Science ®Google Scholar
• Zhou X, Li Y, Shi X, et al. An overview on therapeutics attenuating amyloid β level in Alzheimer’s disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels. Am J Transl Res. 2016;8(2):246.
   PubMed Web of Science ®Google Scholar
• Mhillaj E, Cuomo V, Mancuso C. The contribution of transgenic and nontransgenic animal models in Alzheimer’s disease drug research and development. Behav Pharmacol. 2017;28(2 and 3-Special Issue):95–111.
   PubMed Web of Science ®Google Scholar
• Pasqualetti G, Brooks DJ, Edison P. The role of neuroinflammation in dementias. Curr Neurol Neurosci Rep. 2015;15(4):1–11.
   Web of Science ®Google Scholar
• Bennett S, Grant MM, Aldred S. Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. J Alzheimer's Dis. 2009;17(2):245–257.
   PubMed Web of Science ®Google Scholar
• Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007;47:89–116.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Yamamoto M. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal. 2005;7(3–4):385–394.
   PubMed Web of Science ®Google Scholar
• Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53:401–426.
   PubMed Web of Science ®Google Scholar
• Nissen SE, Tuzcu EM, Schoenhagen P, et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med. 2005;352(1):29–38.
   PubMed Web of Science ®Google Scholar
• Geifman N, Brinton RD, Kennedy RE, et al. Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease. Alzheimers Res Ther. 2017;9(1):10.
   PubMed Web of Science ®Google Scholar
• Bai S, Song Y, Huang X, et al. Statin use and the risk of Parkinson's disease: an updated meta-analysis. PLoS One. 2016;11(3):e0152564.
   PubMed Web of Science ®Google Scholar
• Lin KD, Yang CY, Lee MY, et al. Statin therapy prevents the onset of Parkinson disease in patients with diabetes. Ann Neurol. 2016;80(4):532–540.
   PubMed Web of Science ®Google Scholar
• Adams SP, Sekhon SS, Wright JM. Lipid-lowering efficacy of rosuvastatin. The Cochrane Library. 2014. doi:10.1002/14651858.CD010254.pub2.
   Google Scholar
• Kapur NK, Musunuru K. Clinical efficacy and safety of statins in managing cardiovascular risk. Vasc Health Risk Manag. 2008;4(2):341.
   PubMedGoogle Scholar
• Koc ER, Ersoy A, Ilhan A, et al. Is rosuvastatin protective against on noise-induced oxidative stress in rat serum? Noise Health. 2015;17(74):11.
   PubMed Web of Science ®Google Scholar
• Mahalwar R, Khanna D. Pleiotropic antioxidant potential of rosuvastatin in preventing cardiovascular disorders. Eur J Pharmacol. 2013;711(1):57–62.
   PubMed Web of Science ®Google Scholar
• Barone E, Cenini G, Di Domenico F, et al. Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action. Pharmacol Res. 2011;63(3):172–180.
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Barone E, Mancuso C. Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders. Pharmacol Res. 2011;64(3):180–186.
   PubMed Web of Science ®Google Scholar
• Flicker L, Grimley Evans J. Piracetam for dementia or cognitive impairment. The Cochrane Library. 2004. doi:10.1002/14651858.CD001011.
   Google Scholar
• Husain I, Akhtar M, Abdin MZ, et al. Rosuvastatin ameliorates cognitive impairment in rats fed with high-salt and cholesterol diet via inhibiting acetylcholinesterase activity and amyloid beta peptide aggregation. Hum Exp Toxicol. 2017. doi:10.1177/0960327117705431.
   PubMed Web of Science ®Google Scholar
• Husain I, Akhtar M, Vohora D, et al. Rosuvastatin attenuates high-salt and cholesterol diet induced neuroinflammation and cognitive impairment via preventing nuclear factor KappaB pathway. Neurochem Res. 2017;42(8):2404–2416.
   PubMed Web of Science ®Google Scholar
• Ghaisas MM, Dandawate PR, Zawar SA, et al. Antioxidant, antinociceptive and anti-inflammatory activities of atorvastatin and rosuvastatin in various experimental models. Inflammopharmacology. 2010;18(4):169–177.
   PubMedGoogle Scholar
• Hsieh M-T, Tsai F-H, Lin Y-C, et al. Effects of ferulic acid on the impairment of inhibitory avoidance performance in rats. Planta Med. 2002;68(08):754-756.
   PubMedGoogle Scholar
• Gu SM, Park MH, Hwang CJ, et al. Bee venom ameliorates lipopolysaccharide-induced memory loss by preventing NF-kappaB pathway. J Neuroinflammation. 2015;12(1):1.
   Google Scholar
• Friesner RA, Banks JL, Murphy RB, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004;47(7):1739–1749.
   PubMed Web of Science ®Google Scholar
• Lo SC, Li X, Henzl MT, et al. Structure of the Keap1: Nrf2 interface provides mechanistic insight into Nrf2 signaling. EMBO J. 2006;25(15):3605–3617.
   PubMed Web of Science ®Google Scholar
• Siddiqui N, Alam MS, Ali R, et al. Synthesis of new benzimidazole and phenylhydrazinecarbothiomide hybrids and their anticonvulsant activity. Med Chem Res. 2016;25(7):1390–1402.
   Web of Science ®Google Scholar
• Husain I, Akhtar M, Madaan T, et al. Tannins enriched fraction of emblica officinalis fruits alleviates high-salt and cholesterol diet-induced cognitive impairment in rats via Nrf2–ARE pathway. Front Pharmacol. 2018;9:23.
   PubMed Web of Science ®Google Scholar
• Husain I, Akhtar M, Shaharyar M, et al. High-salt-and cholesterol diet-associated cognitive impairment attenuated by tannins-enriched fraction of emblica officinalis via inhibiting NF-kB pathway. Inflammopharmacology. 2018;26(1):147–156. doi:10.1007/s10787-017-0437-x.
   PubMed Web of Science ®Google Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70–77.
   PubMed Web of Science ®Google Scholar
• Wheeler CR, Salzman JA, Elsayed NM, et al. Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Anal Biochem. 1990;184(2):193–199.
   PubMed Web of Science ®Google Scholar
• Hassan MQ, Akhtar MS, Akhtar M, et al. Edaravone protects rats against oxidative stress and apoptosis in experimentally induced myocardial infarction: biochemical and ultrastructural evidence. Redox Report. 2015;20(6):275–281.
   PubMed Web of Science ®Google Scholar
• Utley HG, Bernheim F, Hochstein P. Effect of sulfhydryl reagents on peroxidation in microsomes. Arch Biochem Biophys. 1967;118(1):29–32.
   Web of Science ®Google Scholar
• Waseem M, Parvez S. Mitochondrial dysfunction mediated cisplatin induced toxicity: modulatory role of curcumin. Food Chem Toxicol. 2013;53:334–342.
   PubMed Web of Science ®Google Scholar
• Dragicevic N, Mamcarz M, Zhu Y, et al. Mitochondrial amyloid-β levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. J Alzheimer's Dis. 2010;20(S2):535–550.
   Google Scholar
• Ly JD, Grubb D, Lawen A. The mitochondrial membrane potential (Δψm) in apoptosis: an update. Apoptosis. 2003;8(2):115–128.
   PubMed Web of Science ®Google Scholar
• Brand MD, Esteves TC. Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab. 2005;2(2):85–93.
   PubMed Web of Science ®Google Scholar
• Wang D-M, Li S-Q, Wu W-L, et al. Effects of long-term treatment with quercetin on cognition and mitochondrial function in a mouse model of Alzheimer’s disease. Neurochem Res. 2014;39(8):1533–1543.
   PubMed Web of Science ®Google Scholar
• Gurtu V, Kain SR, Zhang G. Fluorometric and colorimetric detection of caspase activity associated with apoptosis. Anal Biochem. 1997;251(1):98–102.
   PubMed Web of Science ®Google Scholar
• Nguyen D, Zhou T, Shu J, et al. Quantifying chromogen intensity in immunohistochemistry via reciprocal intensity. Cancer InCytes. 2013;2(1):1. doi:10.1038/protex.2013.097.
   Google Scholar
• Pennartz S, Reiss S, Biloune R, et al. Generation of single-cell suspensions from mouse neural tissue. JoVE (J Visualized Exp). 2009;29:e1267.
   Google Scholar
• Shah SA, Khan M, Jo MH, et al. Melatonin stimulates the SIRT1/Nrf2 signaling pathway counteracting lipopolysaccharide (LPS)-induced oxidative stress to rescue postnatal Rat brain. CNS Neurosci Ther. 2017;23(1):33–44.
   PubMed Web of Science ®Google Scholar
• Dasgupta A, Klein K. Antioxidants in food, vitamins and supplements: prevention and treatment of disease. Houston: Elsevier; 2014.
   Google Scholar
• Mannervik B, Board PG, Hayes JD, et al. Nomenclature for mammalian soluble glutathione transferases. Methods in Enzymology. 2005;401:1–8.
   PubMed Web of Science ®Google Scholar
• Shooshtari P, Fortuno ES, Blimkie D, et al. Correlation analysis of intracellular and secreted cytokines via the generalized integrated mean fluorescence intensity. Cytometry Part A. 2010;77(9):873–880.
   PubMedGoogle Scholar
• Petri S, Körner S, Kiaei M. Nrf2/ARE signaling pathway: key mediator in oxidative stress and potential therapeutic target in ALS. Neurol Res Int. 2012;2012:1–7.
   Google Scholar
• Reichard JF, Motz GT, Puga A. Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1. Nucleic Acids Res. 2007;35(21):7074–7086.
   PubMed Web of Science ®Google Scholar
• Kerr F, Sofola-Adesakin O, Ivanov DK, et al. Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease. PLoS Genet. 2017;13(3):e1006593.
   PubMed Web of Science ®Google Scholar
• Nagel JA, Kemble ED. Effects of amygdaloid lesions on the performance of rats in four passive avoidance tasks. Physiol Behav. 1976;17(2):245–250.
   PubMed Web of Science ®Google Scholar
• Pinton S, Brüning CA, Oliveira CES, et al. Therapeutic effect of organoselenium dietary supplementation in a sporadic dementia of Alzheimer's type model in rats. J Nutr Biochem. 2013;24(1):311–317.
   PubMed Web of Science ®Google Scholar
• Joshi G, Johnson JA. The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases. Recent Pat CNS Drug Discovery. 2012;7(3):218–229.
   PubMedGoogle Scholar
• Kishi T, Hirooka Y. Oxidative stress in the brain causes hypertension via sympathoexcitation. Front Physiol. 2012;3:335.
   PubMed Web of Science ®Google Scholar
• Ketonen J, Mervaala E. Effects of dietary sodium on reactive oxygen species formation and endothelial dysfunction in low-density lipoprotein receptor-deficient mice on high-fat diet. Heart Vessels. 2008;23(6):420–429.
   PubMed Web of Science ®Google Scholar
• Friedland-Leuner K, Stockburger C, Denzer I, et al. Mitochondrial dysfunction: cause and consequence of Alzheimer's disease. Prog Mol Biol Transl Sci. 2013;127:183–210.
   Web of Science ®Google Scholar
• Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, et al. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology. 1995;21(5):1465–1468.
   PubMed Web of Science ®Google Scholar